Role of Retinoblastoma Protein Family (Rb/p105 and Rb2/p130) Expression in the Histopathological Classification of Borderline Ovarian Tumors-Reference-Cited by-同舟云学术

Role of Retinoblastoma Protein Family (Rb/p105 and Rb2/p130) Expression in the Histopathological Classification of Borderline Ovarian Tumors

Published:2020-11-11 Issue: Volume:7 Page:
ISSN:2296-858X
Container-title:Frontiers in Medicine
language:
Short-container-title:Front. Med.

Author:

Masciullo Valeria,Valdivieso Paola,Amadio Giulia,Santoro Angela,Angelico Giuseppe,Sgambato Alessandro,Boffo Silvia,Giordano Antonio,Scambia Giovanni,Zannoni Gian Franco

Publisher

Frontiers Media SA

Subject

General Medicine

Reference29 articles.

1. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators;Seidman;Hum Pathol,2000

2. Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria;Hauptmann;Virchows Arch,2017

3. Ovarian mucinous tumors of low malignant potential: a clinicopathologic study of 54 tumors of intestinal and mullerian type;Siriaunkgul;Int J Gynecol Pathol,1995

4. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis;Sherman;Cancer,2004

5. The behavior of serous tumors of low malignant potential: are they ever malignant?;Kurman;Int J Gynecol Pathol,1993

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in understanding the molecular mechanisms of borderline ovarian tumors;Frontiers in Molecular Biosciences;2024-08-30

2. Cannabinol Regulates the Expression of Cell Cycle-Associated Genes in Motor Neuron-like NSC-34: A Transcriptomic Analysis;Biomedicines;2024-06-17

3. The pathophysiology of the cell cycle in cancer and treatment strategies using various cell cycle checkpoint inhibitors;Pathology - Research and Practice;2023-11

4. Identifying novel SMYD3 interactors on the trail of cancer hallmarks;Computational and Structural Biotechnology Journal;2022